Her scientific interests lie mostly in Immunology, Internal medicine, Leukemia, Juvenile myelomonocytic leukemia and Oncology. The concepts of her Immunology study are interwoven with issues in Hematopoietic stem cell transplantation, Transplantation, Germline mutation and Haematopoiesis, Bone marrow failure. Her study on Internal medicine is mostly dedicated to connecting different topics, such as Surgery.
Her Leukemia research incorporates themes from Survival rate, Myeloid, Myeloid leukemia, Cytogenetics and Bone marrow. Her Juvenile myelomonocytic leukemia study combines topics from a wide range of disciplines, such as Cancer research, Noonan syndrome, Myelodysplastic syndromes, PTPN11 and Chromosome 7. Charlotte M. Niemeyer interconnects Myeloproliferative Disorders and NPM1 in the investigation of issues within Oncology.
Charlotte M. Niemeyer focuses on Internal medicine, Immunology, Juvenile myelomonocytic leukemia, Cancer research and Leukemia. Her Internal medicine research integrates issues from Gastroenterology and Oncology. Her Gastroenterology study incorporates themes from Surgery and Chemotherapy.
The Immunology study combines topics in areas such as Haematopoiesis and Bone marrow failure. Juvenile myelomonocytic leukemia is a primary field of her research addressed under Genetics. Her Leukemia research incorporates elements of Myeloid and Myeloid leukemia.
Her main research concerns Juvenile myelomonocytic leukemia, Internal medicine, Cancer research, Hematopoietic stem cell transplantation and Immunology. Her Internal medicine research includes themes of Gastroenterology and Oncology. Her work deals with themes such as Haematopoiesis, Stem cell, KRAS, Leukemia and Epigenetics, which intersect with Cancer research.
Her research in Leukemia focuses on subjects like Myeloid, which are connected to Genetics. Her study on Hematopoietic stem cell transplantation also encompasses disciplines like
Charlotte M. Niemeyer spends much of her time researching Myelodysplastic syndromes, Cancer research, Leukemia, Juvenile myelomonocytic leukemia and Germline mutation. Myelodysplastic syndromes is a subfield of Immunology that she studies. Her Cancer research research is multidisciplinary, incorporating perspectives in KRAS, Haematopoiesis, Stem cell and Transplantation.
Leukemia is the subject of her research, which falls under Internal medicine. Her Juvenile myelomonocytic leukemia research is multidisciplinary, relying on both Neuroblastoma RAS viral oncogene homolog, Intensive care medicine, DNA methylation and PTPN11. Her Germline mutation research is classified as research in Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
Marco Tartaglia;Charlotte M Niemeyer;Alessandra Fragale;Alessandra Fragale;Xiaoling Song.
Nature Genetics (2003)
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.
Martin Schrappe;Alfred Reiter;Wolf-Dieter Ludwig;Jochen Harbott.
The landscape of genomic alterations across childhood cancers
Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter.
Germline KRAS mutations cause Noonan syndrome
Suzanne Schubbert;Martin Zenker;Sara L . Rowe;Silke Böll.
Nature Genetics (2006)
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
Anja Möricke;Alfred Reiter;Martin Zimmermann;Helmut Gadner.
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A Möricke;M Zimmermann;A Reiter;G Henze.
A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases
H Hasle;C M Niemeyer;J M Chessells;I Baumann.
Chronic myelomonocytic leukemia in childhood. A retrospective analysis of 110 cases.
C.M. Niemeyer;M. Aricó;G. Basso;A. Biondi.
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol;Sofia Kade;Carola Schlarmann;Patrick Löffeld.
Ribosomal Protein L5 and L11 Mutations Are Associated with Cleft Palate and Abnormal Thumbs in Diamond-Blackfan Anemia Patients
Hanna T. Gazda;Hanna T. Gazda;Mee Rie Sheen;Adrianna Vlachos;Adrianna Vlachos;Valerie Choesmel;Valerie Choesmel.
American Journal of Human Genetics (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: